These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25742123)

  • 21. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.
    Nkadi PO; Merritt TA; Pillers DA
    Mol Genet Metab; 2009 Jun; 97(2):95-101. PubMed ID: 19299177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
    Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
    J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary surfactant proteins A and D: innate immune functions and biomarkers for lung diseases.
    Takahashi H; Sano H; Chiba H; Kuroki Y
    Curr Pharm Des; 2006; 12(5):589-598. PubMed ID: 16472150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of the hydrophilic surfactant proteins A and D.
    Floros J; Hoover RR
    Biochim Biophys Acta; 1998 Nov; 1408(2-3):312-22. PubMed ID: 9813381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.
    Crouch E; Persson A; Chang D; Parghi D
    Am J Pathol; 1991 Oct; 139(4):765-76. PubMed ID: 1656758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the enigma: The emerging significance of pulmonary surfactant proteins in predicting, diagnosing, and managing COVID-19.
    Bastani MN; Jalilian S
    Immun Inflamm Dis; 2024 Jun; 12(6):e1302. PubMed ID: 38860749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema.
    Clark H; Reid K
    Arch Dis Child; 2003 Nov; 88(11):981-4. PubMed ID: 14612363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: The intersection of surfactant homeostasis and innate host defense of the lung: lessons from newborn infants.
    Whitsett JA
    Innate Immun; 2010 Jun; 16(3):138-42. PubMed ID: 20351134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling.
    Olmeda B; Martínez-Calle M; Pérez-Gil J
    Ann Anat; 2017 Jan; 209():78-92. PubMed ID: 27773772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alveolar lipids in pulmonary disease. A review.
    Agudelo CW; Samaha G; Garcia-Arcos I
    Lipids Health Dis; 2020 Jun; 19(1):122. PubMed ID: 32493486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surfactant protein B and C analogues.
    Walther FJ; Gordon LM; Zasadzinski JA; Sherman MA; Waring AJ
    Mol Genet Metab; 2000; 71(1-2):342-51. PubMed ID: 11001826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrophobic surfactant proteins and their analogues.
    Walther FJ; Waring AJ; Sherman MA; Zasadzinski JA; Gordon LM
    Neonatology; 2007; 91(4):303-10. PubMed ID: 17575474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of human polymorphonuclear leukocyte elastase upon surfactant proteins in vitro.
    Liau DF; Yin NX; Huang J; Ryan SF
    Biochim Biophys Acta; 1996 Jul; 1302(2):117-28. PubMed ID: 8695661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In defense of the lung: surfactant protein A and surfactant protein D.
    Kingma PS; Whitsett JA
    Curr Opin Pharmacol; 2006 Jun; 6(3):277-83. PubMed ID: 16580255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.
    Citti A; Peca D; Petrini S; Cutrera R; Biban P; Haass C; Boldrini R; Danhaive O
    Ultrastruct Pathol; 2013 Oct; 37(5):356-65. PubMed ID: 24047351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfactant proteins a and d and pulmonary host defense.
    Crouch E; Wright JR
    Annu Rev Physiol; 2001; 63():521-54. PubMed ID: 11181966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant protein A (SP-A): the alveolus and beyond.
    Khubchandani KR; Snyder JM
    FASEB J; 2001 Jan; 15(1):59-69. PubMed ID: 11149893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical and clinical aspects of pulmonary surfactant proteins].
    Akino T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():5-14. PubMed ID: 1306239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant protein A and surfactant protein D variation in pulmonary disease.
    Sorensen GL; Husby S; Holmskov U
    Immunobiology; 2007; 212(4-5):381-416. PubMed ID: 17544823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.